A Wnt Survival Guide: From Flies to Human Disease  by Chien, Andy J. et al.
A Wnt Survival Guide: From Flies to Human Disease
Andy J. Chien1, William H. Conrad1 and Randall T. Moon1
It has been two decades since investigators discov-
ered the link between the Drosophila wingless (Wg)
gene and the vertebrate oncogene int-1, thus estab-
lishing the family of signaling proteins known as
Wnts. Since the inception of the Wnt signaling field,
there have been 19 Wnt isoforms identified in
humans. These secreted glycoproteins can activate at
least two distinct signaling pathways in vertebrate
cells, leading to cellular changes that regulate a vast
array of biological processes, including embryonic
development, cell fate, cell proliferation, cell migra-
tion, stem cell maintenance, tumor suppression, and
oncogenesis. In certain contexts, one subset of Wnt
isoforms activates the canonical Wnt/b-catenin path-
way that is characterized by the activation of certain
b-catenin-responsive target genes in response to the
binding of Wnt ligand to its cognate receptors.
Similarly, a second subset of Wnt isoforms activates
b-catenin-independent pathways, including the Wnt/
calcium (Wnt/Ca) pathway and the Wnt/planar cell
polarity (Wnt/PCP) pathway, in certain cellular con-
texts. In addition, research has identified several
secreted proteins known to regulate Wnt signaling,
including the Dickkopf (DKK) family, secreted
Frizzled-related proteins (sFRPs), and Wnt inhibitory
factor-1 (WIF-1). The advent of technologies that can
provide genome-wide expression data continues to
implicate Wnts and proteins that regulate Wnt signal-
ing pathways in a growing number of disease
processes. The aim of this review is to provide a
context on the Wnt field that will facilitate the
interpretation and study of Wnt signaling in the
context of human disease.
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INTRODUCTION
Advances in both microarray-based transcriptional profiling
and epigenetics have played important roles in identifying
diseases where changes in Wnt signaling may be involved.
Today, it seems that almost any type of genome-wide
profiling will result in the observations of altered regulation
or silencing of at least one or more proteins implicated in
Wnt signaling. Our aim is to place the current state of
knowledge regarding Wnt signaling in a context that will be
helpful for investigators studying diseases where different
Wnt proteins may be implicated by microarray or epigenetic
studies. By capitalizing on experimental observations of
Wnt function in model systems, researchers can develop
predictions and hypotheses regarding the role of Wnts in
disease models that can be tested with some of the tools
and techniques developed over the past 20 years. This review
will trace the development of our understanding of Wnt
signaling over the past two decades, along with the role of
Wnt isoforms, receptor context, secreted Wnt inhibitors, and
the techniques used to evaluate Wnt signaling in disease
states.
Wnt signaling in the skin
Wnt signaling has been implicated in almost all types of
fundamental disease processes relevant to the skin, including
inflammation, cancer, wound repair, stem cell biology, and
aging (Moon et al., 2004; Brack et al., 2007; Chien and
Moon, 2007; Liu et al., 2007; Manolagas and Almeida,
2007). Furthermore, every major cell type in the adult skin is
dependent on regulation by Wnt signaling, which accounts
for the large body of literature surrounding the central role of
this pathway in skin biology. Seminal studies revealed that
Wnts are critical for determining the fate of epidermal stem
cells, solidifying their role as one of the master regulators of
skin development, skin maintenance, and skin repair and
regeneration (Kishimoto et al., 2000; Huelsken et al., 2001;
Merrill et al., 2001; DasGupta et al., 2002). In the case of hair
follicles, where the role of Wnt signaling has been defined as
well as in any adult tissue niche, Wnts regulate hair follicle
development, the entry of follicle cells into the active growth
phase, and even the regeneration of hair follicles after
wounding (Andl et al., 2002; Van Mater et al., 2003; Ito
et al., 2007; Narhi et al., 2008; Zhang et al., 2008). Aberrant
activation of this pathway is seen in the majority of
pilomatricomas, further highlighting the role of this pathway
in promoting follicular cell fate (Chan et al., 1999). In
addition, Wnt signaling is critical in cutaneous oncogenesis
as both a regulator of pathological Hedgehog pathway
responses (Hoseong Yang et al., 2008) and as an essential
factor for maintaining cancer stem cells in models of
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squamous cell carcinoma (Malanchi et al., 2008). Wnts
play a critical role in the development of epidermal
melanocytes, and are one of only three factors (in addition
to endothelin and stem cell factor) that are necessary to
differentiate a human embryonic stem cell into a fully
functional melanocyte (Fang et al., 2006). In the case of
malignant melanoma, Wnt signaling has been linked to
metastatic progression and patient prognosis (Bittner et al.,
2000; Kageshita et al., 2001; Weeraratna et al., 2002; Carr
et al., 2003; Maelandsmo et al., 2003; Weeraratna, 2005;
Hoek et al., 2006). The recent discovery that the X-linked
genodermatosis known as focal dermal hypoplasia (Goltz’s
syndrome) is directly linked to Wnt signaling further high-
lights the importance of this pathway in both normal human
development and skin biology (Grzeschik et al., 2007; Wang
et al., 2007).
The Wnt/b-catenin signaling pathway
The history of Wnt research highlights the value of develop-
mental models such as Drosophila, Xenopus, and zebrafish,
which have been instrumental in the seminal studies that
defined this signaling pathway and shaped the canonical
model of Wnt/b-catenin signaling that we know today.
Twenty years ago, the realization that the Drosophila
wingless (Wg) gene and the vertebrate int-1 oncogene are
orthologs heralded the birth of the Wnt signaling field
(Rijsewijk et al., 1987). At that time, some of the early
understanding of the biochemical and molecular events
involved in oncogenesis was being developed, and this initial
finding indicated that a pathway used for the development of
an organism could participate in the process of oncogenesis.
The discovery that ectopic expression of the vertebrate int-1/
Wnt-1 oncogene in Xenopus embryos results in axis
duplication and two-headed frogs further solidified the role
of Wnt as an important regulator of both embryonic
development and oncogenesis (McMahon and Moon,
1989). In the intervening two decades, an abundance of
research has clarified the mechanisms by which Wnt and
other developmental pathways can be aberrantly regulated
during oncogenesis and other disease processes.
The link between Wnt and b-catenin was first made in
1990, when a study in Drosophila made a seminal obser-
vation linking Wnt/Wg to post-translational regulation of the
segment polarity gene armadillo, the Drosophila homolog for
vertebrate b-catenin (Riggleman et al., 1990). In the next few
years, data emerged linking armadillo/b-catenin to adherens
junctions and also to a protein known as adenomatous
polyposis coli, which was already implicated in familial
adenomatous polyposis (McCrea et al., 1991; Rubinfeld
et al., 1993). Together, these studies implicated b-catenin
in both cell adhesion and tumor formation. In 1995,
investigators showed that overexpression of certain domains
of b-catenin in Xenopus led to axis duplication, which was
similar to the initial findings with Wnt-1 overexpression,
implying that b-catenin had roles in signaling that were
independent of its role in cell adhesion (Funayama et al.,
1995). As these results solidified the role of Wnt in
oncogenesis, researchers began earnestly characterizing the
ability of Wnt isoforms to induce the transformation of cancer
cells.
Intense interest in the developing field of Wnt signaling
combined with innovations in molecular biology led to rapid
identification of progressively more vertebrate Wnt isoforms,
each displaying seemingly unique patterns of expression
during vertebrate development. Indeed, developmental mod-
els continue to provide pioneering insight into the molecular
mechanisms underlying Wnt signaling. In 1994, genetic
studies identified a critical role for a protein known as
Dishevelled (Dsh/Dvl) in propagating the Wnt/Wg signal
(Klingensmith et al., 1994; Noordermeer et al., 1994). The
same year genetic studies showed that the Drosophila zeste-
white 3/Shaggy protein, a homolog of the vertebrate enzyme
glycogen synthase kinase 3 (GSK3), regulated cellular
armadillo/b-catenin in a manner that opposed a Wnt/Wg
signal (Peifer et al., 1994). The requirement for zw3/Shaggy/
GSK3 in mediating Wnt/Wg signaling in the developing fly
leg further highlighted the importance of this enzyme (Diaz-
Benjumea and Cohen, 1994). A key paper that established
the principal regulation of the pathway came, interestingly,
from studies in frog embryos (Yost et al., 1996). This paper
was the first to show that GSK3 directly phosphorylates
b-catenin, that this phosphorylation resulted in the degrada-
tion of b-catenin, and that mutating the GSK3 phosphoryla-
tion sites resulted in a stable, hyperactive b-catenin.
Moreover, this was the first paper to show that b-catenin
was found in the nucleus, and that this nuclear accumulation
was directly controlled by the regulated post-translational
stability of b-catenin. Following the demonstration that b-
catenin levels increased upon binding of Wnt ligand to Fzd
receptors in Drosophila cells, these collective data formed
the foundation for our current model (Figure 1) of Wnt/b-
catenin signaling (Bhanot et al., 1996; Yang-Snyder et al.,
1996).
Wnt/b-catenin signaling, 20 years later
The current model of Wnt/b-catenin signaling appears to be
quite well conserved in both vertebrates and invertebrates,
although many fundamental molecular events remain unclear
despite two decades of intense research (Figure 1). For
example, although it is widely recognized that binding of
Wnt ligand to Fzd and low-density lipoprotein receptor-
related protein 5/6 (LRP5/6) co-receptors leads to the
activation of Dvl, our understanding of the molecular
mechanisms underlying Dvl activation remains incomplete.
Furthermore, the exact sequence of events that allows Dvl to
inhibit the b-catenin destruction complex is still unsettled, as
is the role of nuclear localization of Dvl. Recent studies also
suggest that the regulation of Dvl degradation can play a
critical role in modulating the signaling pathway (Angers
et al., 2006; Chan et al., 2006). Although it is well-accepted
that the phosphorylation of b-catenin by GSK3 leads to
ubiquitination and subsequent proteasomal degradation,
recent studies continue to identify new members involved
in modulating the b-catenin destruction complex, including
the first X-linked tumor suppressor gene WTX (Major et al.,
2007). Although the activation of transcriptional changes by
www.jidonline.org 1615
AJ Chien et al.
A Wnt Survival Guide
nuclear b-catenin in both developmental and cancer models
has focused primarily on interactions with transcription
factors of the T-cell factor (TCF) and lymphoid-enhancing
factor (LEF) families, recent studies suggest that there may be
still other transcription factors involved in b-catenin signaling
that are yet to be identified (Olson et al., 2006). Most models
of Wnt signaling generally end with the activation of target
genes by b-catenin, whereas the mechanisms involved in
turning off the pathway remain unresolved. Nevertheless, the
current model whereby Wnt binding leads to cellular
phenotypes through the b-catenin-mediated transcriptional
regulation of target genes has provided the basis for
many studies that have lent insight into the role of this
pathway in both embryonic development and the biology of
cancer and other human diseases (Moon et al., 2004; Chien
and Moon, 2007).
b-Catenin-independent Wnt signaling pathways
As more Wnt isoforms were identified, it soon became clear
that the Wnt/b-catenin model was not sufficient to explain the
actions of all identified Wnt isoforms. Early studies with
Xenopus Wnt-5a showed that overexpression of this isoform
led to effects that were distinct from the axis duplication and
neural malformations seen with Xenopus Wnt-1, Wnt-3, or
Wnt-8 (Moon et al., 1993). Thus, in Xenopus, this class of
Wnts appeared to affect cell movements rather than cell fate,
which was different than what was observed with Wnt-1,
Wnt-3, and Wnt-8. The classification of Wnt signaling
was further refined based on studies in other systems into
two main pathways: (1) the transforming, dorsalizing, or
axis-inducing class and (2) the non-transforming class
(see Table 1). The class of transforming, dorsalizing, or
axis-inducing Wnts displayed phenotypes in animal models
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Figure 1. A simplified representation of Wnt/b-catenin and b-catenin-independent signaling pathways. In the absence of Wnt ligand (far left), the ‘‘destruction
complex’’ composed of the core proteins Axin, adenomatous polyposis coli (APC), and glycogen synthase kinase-3 (GSK3) rapidly phosphorylates (P) cytosolic
b-catenin, targeting it for subsequent ubiquitination (Ub) and proteasome-mediated destruction. Binding of Wnt to Frizzled (Fzd) and low-density lipoprotein
receptor-related protein 5/6 (LRP5/6) activates the cytosolic protein Dishevelled (DVL), leading to inhibition of the destruction complex. The resulting
accumulated b-catenin can then translocate to the nucleus to activate Wnt-responsive target genes regulated by TCF and LEF family transcription factors, leading
to various cellular effects. Activation of the small GTPases Rho and Rac can result in cytoskeletal rearrangements that affect cellular motility upon Wnt
stimulation. Binding of Wnt isoforms to either Fzd or receptors such as receptor tyrosine kinase-like orphan receptor 2 (Ror2, a receptor for Wnt-5a), can trigger
b-catenin-independent downstream signaling events, including the inhibition of Wnt/b-catenin signaling. The mechanisms underlying b-catenin-independent
Wnt signaling are not well defined, and may be largely determined by cellular context. The secreted inhibitor Dickkopf (DKK) can antagonize Wnt signaling by
competitively binding to LRP5/6. Secreted Fzd-related proteins (SFRPs) and Wnt inhibitory factor (WIF) are thought to antagonize Wnt signaling by sequestering
Wnt ligand in the extracellular space.
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and cellular models that were similar to b-catenin over-
expression, and today we would categorize these Wnts as
predominantly activators of the Wnt/b-catenin pathway. The
observed b-catenin-independent regulation of polarity, asym-
metric cell division, and morphogenetic movements during
vertebrate gastrulation by these non-transforming Wnts led to
their initial classification as ‘‘non-canonical’’ Wnts, although
the term ‘‘b-catenin-independent Wnts’’ is now preferred
Table 1. Context-specific signaling of different Wnt isoforms
Official
designation
Prior
aliases
Stabilization of
b-catenin
Transformation
of C57MG breast
cells
Activation of
PKC or
CaMKII
Activation of
Rho or Rac
Knockout mouse
phenotype (van
Amerongen and Berns,
2006)
Wnt1 int-1,
Wg
+ (Hinck et al., 1994;
van Leeuwen et al.,
1994; Shimizu et al.,
1997)
Strong (Shimizu
et al., 1997)
ND ND Midbrain and hindbrain
defects
Wnt2 hWnt-
13
+ (Shimizu et al., 1997;
Bafico et al., 1998;
Karasawa et al., 2002)
Strong (Shimizu
et al., 1997)
ND ND Abnormal placental
development
Wnt3 + (Shimizu et al., 1997;
Barrow et al., 2003)
Strong (Shimizu
et al., 1997)
ND + (Kobune
et al., 2007)
Failure to form the A/P axis
before gastrulation
Wnt3a + (Shimizu et al., 1997) Strong (Shimizu
et al., 1997)
ND + (Shi et al.,
2006)
Truncated A/P axis
Wnt4  (Shimizu et al., 1997) No (Wong et al.,
1994; Shimizu
et al., 1997)
ND + (Matsui et al.,
2005; Osafune
et al., 2006)
No renal tubules or
Mullerian ducts
Wnt5a  (Shimizu et al., 1997) No (Wong et al.,
1994; Shimizu
et al., 1997)
+ (Slusarski
et al., 1997a;
Kuhl et al.,
2000; Westfall
et al., 2003)
+ (Jopling and
den Hertog,
2005; Zhu
et al., 2006;
Hayashi et al.,
2007)
Truncated A/P axis, defects
in lung and pancreas
morphogenesis
Wnt5b  (Shimizu et al., 1997) No (Shimizu et al.,
1997); weak (Wong
et al., 1994)
ND ND Viable
Wnt6 + (Shimizu et al., 1997;
Kirikoshi et al., 2001)
Weak (Shimizu
et al., 1997); no
(Wong et al., 1994)
ND ND Viable
Wnt7a + (Lucas and Salinas,
1997; Maye et al.,
2004)
Weak (Shimizu
et al., 1997); strong
(Wong et al., 1994)
ND + (Kengaku
et al., 1998;
Lyu and Joo,
2005)
A/P axis patterning defects;
female and male
reproductive tract
abnormalities
Wnt7b + (Maye et al., 2004) 
(Shimizu et al., 1997)
No (Shimizu et al.,
1997; Naylor et al.,
2000)
+ (Tu et al.,
2007)
+ (Rosso et al.,
2005)
Abnormal placental
development
Wnt8a + (Kelly et al., 1995;
Saitoh et al., 2002;
Katoh and Katoh, 2005)
ND ND ND Viable
Wnt8b + (Kelly et al., 1995;
Saitoh et al., 2002;
Katoh and Katoh, 2005)
ND ND ND Viable
Wnt9a Wnt-14 + (Spater et al., 2006) ND ND ND Skeletal and synovial
abnormalities
Wnt9b Wnt-15 + (Park et al., 2007) Weak (Qian et al.,
2003)
ND ND Urogenital defects
Wnt10a + (Narita et al., 2005) ND ND ND ND
Wnt10b mWnt-
12
+ (Miyoshi et al., 2002) ND ND ND Accelerated myoblast
differentiation
Wnt11 + (Kofron et al., 2007) Yes (Christiansen
et al., 1996)
+ (Koyanagi
et al., 2005;
Matsui et al.,
2005)
+ (Marlow
et al., 2002;
Matsui et al.,
2005; Zhu
et al., 2006)
Renal and ureteral defects
Wnt16 +1 (Mazieres et al.,
2005)
ND ND ND Viable
A/P axis, anterior/posterior axis; CamKII, calmodulin-dependent protein kinase II; ND, not demonstrated; PKC, protein kinase C. þ , experimentally
detected; , experimentally not detected.
1Demonstrated in Wnt-16b isoform, not Wnt-16a.
www.jidonline.org 1617
AJ Chien et al.
A Wnt Survival Guide
(Veeman et al., 2003). It should be noted that the dogmatic
classification of Wnt ligands as either activators of Wnt/b-
catenin signaling or regulators of b-catenin-independent Wnt
signaling is difficult, as it is clear that the pathway activated
by a Wnt isoform can be highly dependent on cellular
context and factors such as the complement of cell surface
Wnt receptors (Mikels and Nusse, 2006). Nevertheless,
several well-studied isoforms appear to consistently activate
one of the two pathways across numerous cellular and
developmental models, and are often referred to in the
literature as a ‘‘canonical Wnt’’ or a ‘‘non-canonical Wnt’’.
Several models for b-catenin-independent Wnt pathways
have been proposed. Genetic studies identified several
putative pathway members that have been implicated in
regulating planar cell polarity (PCP) during Drosophila
development, and these proteins are collectively known as
the Wnt/PCP pathway (Veeman et al., 2003). The observation
that certain b-catenin-independent Wnts can lead to
increases in intracellular calcium (Ca) levels has led to a
model for Wnt/Ca signaling in both developmental biology
models and cultured human cells (see Table 2) (Kohn and
Moon, 2005). The implication of certain proteins in both
Wnt/PCP and Wnt/Ca pathways suggests that they may be
components of the same signaling network rather than two
distinct pathways, although this hypothesis awaits further
experimental confirmation. In any event, the current data
overwhelmingly support the existence of both b-catenin-
dependent and b-catenin-independent Wnt pathways in
vertebrate cells.
In vertebrates, exogenous perturbation of b-catenin-
independent Wnt signaling results in gastrulation phenotypes
called convergent extension defects, which are characterized
by embryos that are shortened along the body axis and
widened in the lateral axis because of defective cell migration
(Veeman et al., 2003). Certain proteins implicated in PCP in
Drosophila exhibit convergent extension defects that are
similar to what is seen upon gain of function or loss of
function of certain b-catenin-independent Wnt isoforms,
supporting the hypothesis that they may be involved in a
common pathway (Veeman et al., 2003). Although diverse
downstream effectors—intracellular Ca, c-Jun N-terminal
kinase, protein kinase C, CaMK, nuclear factor of activated
T-cells (NFAT), and small GTPases such as Rho and Rac—
have been implicated, there is as yet no reliable assay for
measuring b-catenin-independent Wnt activation across
different cell types (see Figure 1). As a consequence, many
studies have relied on developmental models such as mice,
zebrafish, and Xenopus. The phenotypes observed in devel-
opmental models led to the hypothesis that b-catenin-
independent Wnts were involved in the regulation of cell
motility and/or cell adhesion, and studies of b-catenin-
independent Wnt signaling in the context of human cancer
cell lines seem to support this model (Jonsson and Andersson,
2001; Weeraratna et al., 2002; Kurayoshi et al., 2006; Nishita
et al., 2006; Safholm et al., 2006).
Further studies discovered that b-catenin-independent
Wnt pathways can also inhibit Wnt/b-catenin signaling
(Topol et al., 2003; Weidinger and Moon, 2003). Initial
studies showing that overexpression of Wnt-5a in Xenopus
could inhibit the effects of overexpression of the canonical
Wnt-1 isoform provided the first hints that these two
pathways could have antagonistic effects (Torres et al.,
1996). Subsequent studies have supported the hypothesis
that antagonism of Wnt/b-catenin signaling plays a relevant
role in multiple contexts, including limb regeneration
(Stoick-Cooper et al., 2007). Continued studies may even-
tually reveal whether inhibition of Wnt/b-catenin signaling by
b-catenin-independent Wnt isoforms plays a major role in
disease pathogenesis, and also whether activation of
b-catenin-independent Wnt pathways can provide a potential
therapeutic avenue for inhibiting Wnt/b-catenin signaling in
the context of certain disease states.
Wnt signaling and cellular context
The activation of either the Wnt/b-catenin pathway or
b-catenin-independent Wnt pathway appears to be dictated
primarily by the context in which these Wnts are studied. In
Table 2. Evidence for the involvement of intracellular
calcium transients in b-catenin-independent Wnt
signaling
Reference Observed effect on Ca transients or Ca/CamKII
Slusarski et al.
(1997b)
Wnt-5a (but not Wnt-8) led to increased Ca transients
in zebrafish embryos
Slusarski et al.
(1997a)
Overexpression of rat Fzd2 led to increased Ca
transients in zebrafish embryos
Ca transients seen with rat Fzd2 expression are
augmented by the presence of Wnt-5a
Westfall et al.
(2003)
Wnt-11 (but not Wnt-8) activates Ca transients in
zebrafish embryos
Wnt-5b mutant zebrafish display decreased Ca
transients
Dejmek et al.
(2006)
Recombinant Wnt-5a (but not recombinant Wnt-3a)
activated Ca transients in HB2 mammary epithelial
cells
Safholm et al.
(2006)
A formylated hexapeptide of Wnt-5a could mimic
Wnt-5a by inducing Ca transients in MDA-MB-468
breast cancer cells
Kremenevskaja
et al. (2005)
Recombinant Wnt-5a stimulated intracellular Ca
transients in FTC-133 thyroid carcinoma cells
Kuhl et al. (2000) Wnt-5a and Wnt-11 activated CamKII in Xenopus
embryos in a pertussis toxin-dependent manner
This activation of CamKII was blocked by a dominant-
negative Wnt-11 orthologue, but not a dominant-
negative Wnt-8 orthologue
Robitaille et al.
(2002)
Fzd4 activated CamKII in Xenopus embryos
Fzd4 mutants seen in patients with familial exudative
vitreretinopathy did not activate CamKII in Xenopus
embryos
Sheldahl et al.
(2003)
Dishevelled activated Ca transients in zebrafish
embryos
Dishevelled activated CamKII in Xenopus embryos
Garriock and Krieg
(2007)
Wnt-11 in Xenopus embryos signaled through CamKII
to regulate cell movement during fin development
Ca, calcium; CamKII, calmodulin-dependent protein kinase II.
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large part, these contexts have included their observed
phenotypes in gain-of-function and loss-of-function studies
in vertebrate developmental models, their ability to stabilize
and increase cytosolic and nuclear levels of b-catenin, their
ability to activate b-catenin-responsive reporters or gene
targets in different cell lines or organisms, and their ability to
elicit transformation of the C57MG breast cell line (see
Table 1). Together, these types of experimental observations
have provided a guideline for determining whether different
Wnt isoforms have the ability to activate Wnt/b-catenin and
b-catenin-independent Wnt pathways in different models.
Although the specific Wnt isoform often predicts the down-
stream signaling pathway (see Table 1), there are notable
exceptions that are likely due to changes in receptor context.
The importance of receptor context on Wnt signaling was
shown in human embryonic kidney cells, where Wnt-5a can
either activate or inhibit Wnt/b-catenin signaling depending on
the expression of different receptors (Mikels and Nusse, 2006).
Developmental models such as the zebrafish, Xenopus,
and mouse have provided the basis for many of the defining
studies in the field. In these models, loss-of-function studies
from different mutations (such as the Wnt-5b pipetail mutant
or the Wnt-11 silberblick mutant in zebrafish) or from the
targeted knockdown of expression using Wnt-specific mor-
pholinos that block translation or RNA processing have been
particularly revealing regarding the roles and actions of
different Wnt isoforms during embryonic development.
Although gain-of-function studies have been used to show
the potential actions of Wnts in this context, these studies also
lead to non-physiological effects of Wnts in tissues where
they are not normally expressed, and thus require caution
with the interpretation of results. These models provide a
rapid experimental assay for testing the potential function of
Wnt isoforms and Wnt pathway proteins in the well-
characterized context of embryonic development.
It is tempting to try and broadly classify Wnts as either
b-catenin-dependent or b-catenin-independent isoforms, but
the incomplete overlap between observed measures of the
pathway, such as b-catenin stabilization and C57MG
transformation, suggests that other context-specific factors
may be important. For example, some Wnts, such as Wnt-5b
and Wnt-11, display phenotypes associated with b-catenin-
independent Wnt signaling in developmental models, while
also displaying weak transformation properties that more
closely resemble what would be expected with activation of
the Wnt/b-catenin pathway in C57MG breast cells (see
Table 1). There are at least 10 different Fzd isoforms that have
been identified to date, along with a cadre of candidate
b-catenin-independent Wnt receptors, adding further com-
plexity to the equation (Cheyette, 2004; Chien and Moon,
2007). Furthermore, Fzd isoforms form both homo-oligomers
and hetero-oligomers, further confounding efforts to classify
receptor-ligand-binding partners in a broadly reliable manner
(Kaykas et al., 2004). In addition, other properties of Wnt
proteins, such as their secretion, stability, and even their
interaction with other environmental factors such as the
extracellular matrix, may all depend heavily on a cell context
(Bradley and Brown, 1990; Burrus and McMahon, 1995).
So why would vertebrates evolve to have so many
different Wnt isoforms when extensive research has uncov-
ered only two to three distinct pathways? During develop-
ment, the presence of multiple Wnts that activate a shared
b-catenin-dependent or b-catenin-independent pathway may
merely reflect tissue-specific expression patterns rather than
actual functional differences between Wnt isoforms. Wnts are
themselves subjected to post-translational modification
through glycosylation and lipid modifications including
palmitoylation, and these moieties could play an important
role in determining the distinct properties of different Wnt
isoforms (Takada et al., 2006; Komekado et al., 2007;
Kurayoshi et al., 2007). Some of the limitations in studying
different Wnt isoforms derive from the fact that the
purification of these proteins in robustly active forms was
only recently achieved, and as techniques improve, our
understanding of the biological distinctions between isoforms
will undoubtedly be refined (Willert et al., 2003).
Non-Wnt ligands and activation of Wnt/b-catenin signaling
As if combinations between 19 Wnt ligands and 10 Fzd
receptor isoforms were not enough to foster Wnt signaling
diversity between cell types, there are other non-Wnt secreted
proteins that can bind Fzd receptors to activate Wnt/b-catenin
signaling (Hendrickx and Leyns, 2008). The Norrie disease
protein (NDP, also called ‘‘Norrin,’’ encoded by the NDPH
gene) was identified as a high-affinity ligand for FZD4 based
on the astute observation that Ndph mutant mice exhibit
similar vascular defects in the eyes and ears to the mice mutant
in Fzd4 (Xu et al., 2004). Similar to Wnts, NDP binds both
Fzd4 and LRP5/6 co-receptors to stabilize b-catenin and
activate Wnt/b-catenin signaling. In humans, mutations of
NDPH, FZD4, and LRP5 have all been observed in patients
with familial exudative vitreoretinopathy, confirming the
important role of these three proteins in regulating vascular
development of the eye (Chen et al., 1993; Qin et al., 2005).
Another class of proteins in the thrombospondin type-1
repeat superfamily called R-Spondins can also activate Wnt/
b-catenin signaling through FZD and LRP co-receptors
(Kamata et al., 2004; Kazanskaya et al., 2004; Nam et al.,
2006). Spondins also exhibit synergy with Wnt ligands in
activating Wnt/b-catenin signaling, and interestingly are
downregulated with loss of Wnt1 or Wnt3A in mice,
suggesting a possible role in feed-forward signaling (Kamata
et al., 2004). In humans, R-Spondin (encoded by the gene
RSPO1) regulates skin differentiation, sex determination, and
predisposition to squamous cell carcinoma (Parma et al.,
2006). Without these developmental studies, neither Spon-
dins nor NDP exhibit homology to Wnts that would predict
their function as activators of Wnt/b-catenin signaling.
Consequently, it is likely that other as-yet unidentified
proteins may be able to activate Wnt/b-catenin signaling,
either through engagement of FZD and LRP5/6 receptors or
through novel mechanisms.
Secreted Wnt modulators in development and disease
The expression of Wnts in different disease conditions is not
itself sufficient to conclude that Wnt signaling is occurring, as
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certain secreted inhibitors can inhibit Wnt signaling at or
before the level of receptor binding (see Figure 1). Recent
studies implicating Wnts in aging suggest that humoral levels
of Wnt are physiologically relevant, and secreted inhibitors
might also act as important modulators of Wnt signaling both
locally and within an organism’s circulation (Brack et al.,
2007; Liu et al., 2007). During the second decade of the Wnt
field, developmental biologists identified a protein called
Dickkopf-1 (DKK-1) as an antagonist of Wnt signaling (Glinka
et al., 1998). Soon after, a family of DKK proteins was
identified, and of the four known human isoforms, DKK-1
and DKK-4 were shown to inhibit the axis duplication
induced by Wnt/b-catenin activation in Xenopus embryos
(Krupnik et al., 1999). Epistasis experiments with DVL and
FZD indicated that DKK-1 and DKK-4 likely acted upstream
of FZD and DVL in the pathway, which was soon confirmed
by studies demonstrating that DKK-1 potently inhibited Wnt
signaling by binding to the Wnt co-receptor LRP5/6 (Bafico
et al., 2001; Mao et al., 2001; Semenov et al., 2001). Further
studies identified the Kremen family of proteins as a second
class of DKK receptors (Niehrs, 2006). Although studies
indicate that DKK-1, DKK-2, and DKK-4 regulate Wnt/b-
catenin signaling in vertebrate cells, DKK-3 appears to be a
more divergent form of the family both based on its functional
effects and by sequence analysis (Niehrs, 2006). Although all
DKK family members contain a unique DKK-N motif and a
putative co-lipase fold region, DKK-3 also shares a unique
SGY domain with a protein known as DKK-like-1 or Soggy.
Little is known about Soggy outside of a potential role in
spermatogenesis and its homology to DKK-3 (Kaneko and
DePamphilis, 2000; Kohn et al., 2005).
A growing number of studies have implicated DKK family
members in human disease based on transcriptional profiling
and epigenetic studies (Niehrs, 2006). In particular, altera-
tions of DKK expression have been observed in a number of
cancer models, which is not surprising given the importance
of Wnt signaling in cancer biology. Modulation of DKK-1
expression in disease models, including mesothelioma,
Alzheimer’s, and ischemic neuronal injury, has shown some
therapeutic promise (Chien and Moon, 2007). The role of
DKK expression changes as either contributory or compensa-
tory responses is a frequent question that arises during the
interpretation of transcriptional profiling experiments. For
example, in the case of colorectal carcinoma, where the Wnt/
b-catenin activation is clearly an integral player in carcino-
genesis, the observed epigenetic silencing of DKK-1 and
other DKK family genes is likely to contribute further to the
activation of the Wnt/b-catenin pathway (Hoffman et al.,
2004; Kuhnert et al., 2004; Aguilera et al., 2006; Sato et al.,
2007). DKK-1 expression itself can be directly upregulated by
Wnt/b-catenin signaling in a TCF-dependent manner, but this
mechanism appears to be lost through silencing in colon
cancer (Gonzalez-Sancho et al., 2005). By contrast, although
the large majority of hepatoblastoma tumors exhibit nuclear
b-catenin suggestive of the Wnt/b-catenin pathway activa-
tion, over 80% of tumors display increased DKK-1 transcript
relative to normal fetal liver, suggesting that elevated DKK-1
may be potentially be a negative feedback response in
response to the activation of Wnt/b-catenin signaling (Wirths
et al., 2003).
Another potentially interesting twist arises in the case of
DKK-2, which has been shown in Xenopus studies to activate
the Wnt/b-catenin pathway in synergy with overexpression of
certain Fzd receptor isoforms (Wu et al., 2000). This observed
activation of Wnt/b-catenin signaling by DKK-2 is antag-
onized by DKK-1, but as these assays rely in large part on
overexpression, the issue of whether DKK-2 functions as a
true activator of Wnt/b-catenin signaling under normal
physiological conditions remains unresolved (Wu et al.,
2000). In the case of the DKK-2 knockout mouse, the loss of
DKK-2 leads to constitutive Wnt/b-catenin signaling in the
cornea that results in blindness because of the development
of a keratinized epithelium and skin appendages, suggesting
that DKK-2 functions as an inhibitor of Wnt/b-catenin
signaling in the context of this tissue (Mukhopadhyay et al.,
2006). Again, receptor context may play a large role in
determining the action of a secreted ligand, as the ability of
DKK-2 to act as both an activator and an inhibitor of Wnt/b-
catenin signaling could be determined by the expression
levels of different DKK receptors such as LRP5/6 and the
Kremen family of receptors (Niehrs, 2006).
Another class of proteins called secreted Frizzled-related
proteins (sFRPs) were first identified around 1996 and
postulated to be potential modulators of Wnt signaling
(Hoang et al., 1996; Rattner et al., 1997). Currently, there
are five members of the sFRP family in humans, although
sFRP-3 is many times designated as FrzB (Frizzled motif
associated with bone development), reflecting its original
name before the reclassification of these proteins as one
family. Soon after their discovery, studies on these proteins
supported the notion that they could bind Wnts and thus act
as modulators of Wnt/b-catenin signaling (Lin et al., 1997;
Wang et al., 1997a, b; Hoang et al., 1998; Bafico et al.,
1999). Although the sFRPs contain an N-terminal cysteine-
rich domain homologous to the Wnt-binding domain of the
Frizzled receptor, the exact role of this domain in the binding
of Wnt ligand by sFRPs is still unclear (Kawano and Kypta,
2003). Interestingly, this cysteine-rich domain in sFRPs can
dimerize with other sFRPs and also bind Frizzled itself,
suggesting that inhibition of Wnt signaling by sFRPs could
potentially occur either through the binding of soluble Wnt
ligand or the formation of non-functional receptor complexes
with cell-surface Frizzled receptors (Bafico et al., 1999).
Studies from developmental models support the idea that
sFRPs inhibit Wnts that activate either Wnt/b-catenin signal-
ing or b-catenin-independent pathways, which is not entirely
surprising as Wnt isoforms of both classes bind to Frizzled
receptors. However, interpretation of the role of sFRPs in
different tissues and disease states is complicated by the fact
that different sFRP family members can have different, and
even opposing, effects in certain contexts. In breast cancer
cells, sFRP-1 appeared to increased b-catenin levels, whereas
sFRP-2 appeared to have no change or even increased b-
catenin levels (Melkonyan et al., 1997). In the developing
kidney, it appears that sFRP-1 can downregulate Wnt/b-
catenin signaling, whereas sFRP-2 may function as a
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competitive inhibitor of sFRP-1 without directly affecting
Wnt/b-catenin signaling (Yoshino et al., 2001). Coupled with
studies suggesting that sFRP-1 can act as an activator of Wnt/
b-catenin signaling at lower concentrations, it has been
suggested that the sFRPs may act in a biphasic manner, acting
as antagonists when there are lower relative concentrations of
Frizzled receptor, while serving as an activator of Wnt
signaling in the presence of higher relative concentrations of
Frizzled receptor, potentially by augmenting the transport of
Wnt ligand to these sites (Uren et al., 2000; Kawano and
Kypta, 2003). Consequently, the question of how sFRPs may
act in the context of different disease states may not be easily
resolved by simple transcriptional profiling, as the amount of
protein for sFRPs, Frizzled receptors, and Wnt ligand is likely
all relevant to the functional outcome for the cell. Never-
theless, the increasing reports of epigenetic inactivation of
sFRP genes in different cancer models implicate them as
important regulators of oncogenesis (Caldwell et al., 2004;
Lee et al., 2004; Suzuki et al., 2004; Fukui et al., 2005; He
et al., 2005; Marsit et al., 2005, 2006; Zou et al., 2005;
Aguilera et al., 2006; Liu et al., 2006; Qi et al., 2006;
Urakami et al., 2006a; Nojima et al., 2007; Sato et al., 2007).
Wnt-inhibitory factor 1 (WIF-1) is a mysterious protein that
binds Wnt ligands through a unique WIF domain that does
not exhibit homology to the cysteine-rich Wnt-binding
regions of sFRP or Frizzled proteins (Hsieh et al., 1999).
Interestingly, the atypical receptor tyrosine kinase receptor
RYK also contains an extracellular WIF domain, and this
receptor is one of several proteins implicated as a cellular
receptor for the b-catenin-independent Wnt-5a isoform
(Cheyette, 2004; Lu et al., 2004; Keeble et al., 2006; Harris
and Beckendorf, 2007). The exact mechanisms underlying
the regulation of Wnt signals by WIF-1 are not completely
understood, but the observed silencing of WIF-1 in different
cancers along with the effects of WIF-1 gain of function and
loss of function in different cancer models suggests that like
DKKs and sFRPs, this protein likely plays an important role in
oncogenesis and other biological processes related to Wnt
signaling (Wissmann et al., 2003; Mazieres et al., 2004;
Taniguchi et al., 2005; Aguilera et al., 2006; Batra et al.,
2006; Lin et al., 2006, 2007; Tang et al., 2006; Urakami
et al., 2006b).
Interrogating Wnt pathway activation in disease models
Wnt signaling plays an integral role in maintaining cellular
homeostasis, defined as a cell’s ability to maintain a certain
state of differentiation, and the loss or disruption of this
homeostasis can have deleterious consequences that manifest
as both acute and chronic disease states. As a result, the
question of whether Wnt signaling is active in different
diseases has potential diagnostic, prognostic, and therapeutic
implications. Alterations of Wnt signaling in disease can
occur through changes in the expression of Wnt isoforms or
secreted Wnt modulators, and also through mutations that
either activate or inactivate critical components of the Wnt
signaling pathway. The study of Wnt signaling in disease is
further complicated by the complex interaction of this
pathway with other signaling networks (Figure 1), making it
difficult to draw conclusions on the state of Wnt signaling
pathways through transcriptional profiling studies alone.
Consequently, investigators have utilized other experimental
approaches to provide independent corroboration of Wnt
signaling activity. In the context of human disease models,
the following three types of studies are used to substantiate
the involvement of Wnt/b-catenin signaling: (1) staining for
nuclear b-catenin in patient samples; (2) the use of optimized
Wnt-responsive reporter assays to assess pathway activation;
and (3) validation of changes in known endogenous Wnt
target genes.
In the current model of Wnt/b-catenin signaling, the
destruction complex rapidly targets cytosolic b-catenin for
proteasome-mediated degradation in the absence of a Wnt
signal; hence, the presence of nuclear b-catenin would not be
expected without activation of the Wnt/b-catenin pathway by
either ligand binding or perturbation of the pathway down-
stream of the receptor (that is, with a gene mutation or
deletion) resulting in constitutive activation. Consequently,
the presence of nuclear b-catenin has been used as a
β-Catenin-responsive GFP reporter in hESCs
Wnt-stimulated β-galactosidase in the TOPGAL reporter mousea
b
Figure 2. The use of Wnt reporters can provide important information on
the status of Wnt/b-catenin signaling in animal and cell models. (a)
Transgenic BATGAL mice (Maretto et al., 2003) contain the lacZ reporter
gene downstream of an optimized b-catenin/TCF promoter, allowing both the
temporal and spatial visualization of active Wnt/b-catenin signaling (blue
areas) in a mouse embryo (E11.5) after a b-galactosidase reaction. The boxed
area is magnified to show that Wnt/b-catenin activation in individual cells can
be readily assessed. Bar¼1mm. (b) Cultured H1 human embryonic stem cells
(hESCs) stably expressing GFP downstream of an optimized b-catenin/TCF
promoter allow visualization of endogenous Wnt/b-catenin pathway
activation in embryoid bodies. This reporter allows ready visualization of
asymmetric endogenous Wnt/b-catenin signaling in cells within a single
embryoid body by comparing the light micrograph (left panel) to the GFP
image (right panel). Bar¼ 100 mM.
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surrogate marker of Wnt activation in histopathology studies
of patient samples. Studies in animal models and cell culture
models using other corroborating experimental measures of
Wnt signaling have supported the fact that the Wnt/b-catenin
pathway activation is indeed accompanied by the nuclear
translocation of b-catenin, and in the case of archived patient
tissues where extraction of proteins and nucleic acids can be
technically limited, staining for nuclear b-catenin may be the
only available method for determining Wnt/b-catenin path-
way status.
There are caveats that investigators should recognize
when trying to interpret the meaning of nuclear b-catenin in
these situations. Although the presence of nuclear b-catenin
likely implies, at the minimum, some prior activation of the
Wnt/b-catenin pathway, there are several nuclear inhibitors
of b-catenin signaling that may function to offset the presence
of nuclear b-catenin in certain contexts (Daniels and Weis,
2002; Takemaru et al., 2003; Gottardi and Gumbiner, 2004).
In addition, the lack of observed nuclear b-catenin staining
may reflect technical limitations in detection related to tissue
preservation or antibody sensitivity rather than a definitive
lack of Wnt/b-catenin signaling, as in theory only a few
molecules of nuclear b-catenin may be needed to regulate
critical gene targets after a Wnt signal. A recent report
documenting Smad3-dependent nuclear localization of
b-catenin after activation of the TGFb signaling pathway in
mesenchymal stem cells also suggests that nuclear localiza-
tion of b-catenin may not be entirely limited to Wnt/b-catenin
signaling (Jian et al., 2006). Nevertheless, testing for nuclear
b-catenin can provide important data regarding the role of
Wnt/b-catenin signaling, but should always be interpreted in
the context of other independent corroborative approaches.
Another valuable tool for the study of Wnt/b-catenin
signaling has been the development of optimized TCF-
responsive Wnt/b-catenin reporters that have been success-
fully used in several vertebrate systems, in both transgenic
organisms and cultured cells (Barolo, 2006). The promoters
for these reporters exploit the known regulation of Wnt/b-
catenin-responsive genes by members of the TCF and LEF
family of transcription factors, utilizing multimerized TCF/
LEF-binding sites that are upstream of reporters such as
b-galactosidase, green fluorescent protein , or a luciferase
enzyme to facilitate the measurement of Wnt/b-catenin
signaling by visual or rapid enzymatic assays (Figure 2).
Again, the use of these reporters should be accompanied by
an understanding of their possible limitations. The latest
iterations of these reporters all contain at least 8–12
optimized TCF/LEF-binding sites, which is more than the
1–2 TCF/LEF sites often found in endogenous gene targets
(Barolo, 2006). These reporters will not provide information
in cases where Wnt activation may lead to TCF-independent
transcriptional changes (Olson et al., 2006). Conceivably,
these reporters would also not be able to distinguish Wnt-
mediated activation of TCF-dependent signaling from the
activation of TCF by other mechanisms.
Despite these potential caveats, TCF-responsive Wnt
reporters have proven to be a tremendously reliable and
valuable tool for assessing the response of different cell types
to Wnt signals both in vitro and in vivo while also providing
an easy assay for investigating the role of other proteins in
modulating Wnt/b-catenin signaling. The availability of
control reporters with mutated TCF/LEF-binding sites provides
an additional tool to confirm the specificity of a suspected
Wnt/b-catenin response. In cultured cells, the use of these
Wnt reporter systems allows quantitative comparison of Wnt/
b-catenin activation under different conditions, including
drug treatments and the targeted manipulation of protein
expression in gain-of-function or loss-of-function experi-
ments. In addition to providing a rapid and fairly specific
readout for activation of Wnt/b-catenin signaling across a
wide range of disease models, the high fidelity of these
reporters in cell-based assays has also facilitated high-
throughput screening strategies as a means for further
identifying molecular regulators of this pathway (Major
et al., 2008).
In transgenic models, these reporters can provide valuable
information on the temporal and spatial activation of Wnt/b-
catenin signaling, although quantitative comparisons in these
types of experiments are more difficult (see also Figure 2). To
illustrate some of the limitations of transgenic Wnt reporter
systems, earlier studies have found discrepancies in the
temporal and spatial activation of Wnt reporters while using
different transgenic models to study embryonic development
(reviewed in Barolo, 2006). Our own group has observed
differences between the TOPGAL and BATGAL transgenic
reporter mice with regard to the identification of Wnt/b-
catenin signaling in various adult tissues, which often
necessitates the examination of both models for experimental
studies. The observed differences between various transgenic
lines involve factors such as the design of the promoter region
and transgenic construct, as well as the integration of the
reporter construct within the genome. Together, these
limitations highlight the need to further perform additional
assays validating the activation of Wnt/b-catenin signaling in
different contexts, but do not diminish the role of these
animal reporters as invaluable tools for studying Wnt/b-
catenin signaling in vivo.
Perhaps the most convincing evidence for activation of
Wnt/b-catenin is demonstration of the Wnt-dependent
regulation of an endogenous Wnt target gene. A growing
number of endogenous Wnt target genes have been identified,
and are available online at the curated Wnt homepage (http://
www.stanford.edu/~rnusse/wntwindow.html). These gene
targets have been identified in different tissue contexts, so
the universal applicability of most of these genes as markers of
Wnt signaling is still unclear. However, one particular Wnt
target gene, Axin2 (also known by its aliases of conductin or
Axil), has been regarded as perhaps the most reliable
endogenous target gene for measuring Wnt/b-catenin pathway
activation (Jho et al., 2002). Interestingly, the Axin2 promoter
contains eight TCF/LEF-binding sites that are very similar to the
optimized sites used in multimerized reporters, and the
presence of so many TCF/LEF sites may explain why Axin2
has proven to be a ubiquitous and vigorous endogenous gene
marker of Wnt/b-catenin pathway activation (Jho et al., 2002;
Lustig et al., 2002). The use of techniques such as real-time
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PCR, microarray-based transcriptional profiling, and even
immunohistochemistry can be used to analyze the relative
expression levels of Wnt target genes, facilitating the
quantitative comparison of Wnt/b-catenin pathway activation
under different experimental conditions in both cultured cell
models and whole organisms and tissue.
These approaches all leverage the transcriptional regula-
tion of genes by nuclear b-catenin and TCF/LEF transcription
factors to provide experimental evidence of Wnt/b-catenin
signaling, and the use of multiple approaches can provide
valuable corroborating data when interrogating the status of
Wnt/b-catenin signaling in different disease models. The
availability of these techniques has contributed greatly to
advancing our understanding of the molecular events
involved in Wnt/b-catenin signaling. Conversely, the lack of
similar assays has made the study of b-catenin-independent
Wnt signaling pathways more difficult. As both technology
and our understanding of Wnt signaling continue to advance,
the development of new experimental methods for measuring
Wnt signaling will enhance our understanding of the events
that occur downstream of Wnt binding to its receptor.
CONCLUSIONS
Wnt signaling will undoubtedly be implicated in a growing
number of disease conditions, and identifying the link
between Wnt and disease will rely on the sophisticated
synthesis and interpretation of different lines of experimental
evidence. Given the large numbers of proteins that have been
identified so far as regulators of Wnt signaling, it will be
difficult to assess the involvement of this pathway in a disease
process based on cellular profiling studies alone. However,
available tools including cell-based reporters, transgenic
reporter animals, and an ever-expanding list of Wnt-regulated
target genes offer powerful tools for studying Wnt signaling in
model systems.
Even after 20 years of intense study, there are still many
unanswered questions remaining in Wnt signaling, particu-
larly with regard to its role in human disease. Developmental
biology models that have provided the foundation for this
field will probably further generate valuable and essential
insight into mechanisms underlying Wnt signaling. Ongoing
efforts to study the link between Wnts and a growing number
of disease conditions will uncover details that further
contribute to our understanding of these complex signaling
pathways. Together, these ongoing efforts ensure that a Wnt
review 20 years from now may look quite different, but the
foundation of this field will always be based on a series of
elegant experiments in developmental model systems that
alerted the world of science to the importance of this pathway
in both development and disease.
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